Phathom Pharmaceuticals

Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first in class potassium competitive acid blocker (PCAB)—Phathom is working to transform the…